Form 4: AtriCure Director Karen Prange Acquires Shares Through Restricted Stock Award

Director Karen Prange acquired 7,788 shares of AtriCure, Inc. through a restricted stock award that vests in one year.

Summary

• On May 13, 2024, Karen Prange, a director of AtriCure, Inc., acquired 7,788 shares of common stock.
• The acquisition was made through a restricted stock award under the company's 2023 Stock Incentive Plan.
• The shares will vest on the one-year anniversary of the grant date.
• Following the transaction, Prange directly owns 23,928 shares of AtriCure common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally seen as a positive sign, indicating confidence in the company's future. However, it's a routine transaction related to compensation.

Positives

• The acquisition of shares by a director signals confidence in the company's future prospects.
• The restricted stock award aligns the director's interests with those of the shareholders.

Future Outlook

The shares acquired will vest upon the one-year anniversary of the grant date, indicating a future commitment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates